NO120230B - - Google Patents
Download PDFInfo
- Publication number
- NO120230B NO120230B NO170625A NO17062567A NO120230B NO 120230 B NO120230 B NO 120230B NO 170625 A NO170625 A NO 170625A NO 17062567 A NO17062567 A NO 17062567A NO 120230 B NO120230 B NO 120230B
- Authority
- NO
- Norway
- Prior art keywords
- benzodiazepine
- dihydro
- halogen
- group
- chloro
- Prior art date
Links
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical group 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- -1 alkali metal alkoxide Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- UDLAUVFRZXIQJS-UHFFFAOYSA-N 1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N1C(=O)CN=CC2=CC=CC=C21 UDLAUVFRZXIQJS-UHFFFAOYSA-N 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 2
- FBCCMZVIWNDFMO-UHFFFAOYSA-N dichloroacetyl chloride Chemical compound ClC(Cl)C(Cl)=O FBCCMZVIWNDFMO-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical class NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 1
- RGGLEJFUEMKQSH-UHFFFAOYSA-N 1,4-benzodiazepin-2-one Chemical class O=C1C=NC=C2C=CC=CC2=N1 RGGLEJFUEMKQSH-UHFFFAOYSA-N 0.000 description 1
- PLZWYQYDWCXHTF-UHFFFAOYSA-N 1-methyl-5-phenyl-3h-1,4-benzodiazepin-2-one Chemical compound N=1CC(=O)N(C)C2=CC=CC=C2C=1C1=CC=CC=C1 PLZWYQYDWCXHTF-UHFFFAOYSA-N 0.000 description 1
- HQMWRXORWPOELC-UHFFFAOYSA-N 2-[amino(phenyl)methyl]-4-chloro-n-methylaniline Chemical compound CNC1=CC=C(Cl)C=C1C(N)C1=CC=CC=C1 HQMWRXORWPOELC-UHFFFAOYSA-N 0.000 description 1
- PMOYAPWQLZTKJB-UHFFFAOYSA-N 7-chloro-1-ethyl-5-phenyl-3h-1,4-benzodiazepin-2-one Chemical compound N=1CC(=O)N(CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 PMOYAPWQLZTKJB-UHFFFAOYSA-N 0.000 description 1
- MPJBZKDAPNKHGH-UHFFFAOYSA-N CNC1=C(C(C2=CC=CC=C2)C2=C3C(C(=O)NC3=O)=CC=C2)C=C(C=C1)Cl Chemical compound CNC1=C(C(C2=CC=CC=C2)C2=C3C(C(=O)NC3=O)=CC=C2)C=C(C=C1)Cl MPJBZKDAPNKHGH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- FMCQFYCLUGGPPB-UHFFFAOYSA-N benzhydrylhydrazine Chemical compound C=1C=CC=CC=1C(NN)C1=CC=CC=C1 FMCQFYCLUGGPPB-UHFFFAOYSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid group Chemical group C(C=1C(C(=O)O)=CC=CC1)(=O)O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK605766AA DK115922B (da) | 1966-11-23 | 1966-11-23 | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-oner. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO120230B true NO120230B (de) | 1970-09-21 |
Family
ID=8147110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO170625A NO120230B (de) | 1966-11-23 | 1967-11-21 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3523116A (de) |
| AT (1) | AT283369B (de) |
| CH (1) | CH483435A (de) |
| DE (1) | DE1670006A1 (de) |
| DK (1) | DK115922B (de) |
| ES (1) | ES347463A1 (de) |
| FR (1) | FR1561137A (de) |
| NL (1) | NL6715746A (de) |
| NO (1) | NO120230B (de) |
| SE (1) | SE324371B (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3371085A (en) * | 1959-12-10 | 1968-02-27 | Hoffmann La Roche | 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones |
-
1966
- 1966-11-23 DK DK605766AA patent/DK115922B/da unknown
-
1967
- 1967-11-15 US US683106A patent/US3523116A/en not_active Expired - Lifetime
- 1967-11-16 SE SE15727/67A patent/SE324371B/xx unknown
- 1967-11-18 DE DE19671670006 patent/DE1670006A1/de active Pending
- 1967-11-20 NL NL6715746A patent/NL6715746A/xx unknown
- 1967-11-21 CH CH1628567A patent/CH483435A/de not_active IP Right Cessation
- 1967-11-21 NO NO170625A patent/NO120230B/no unknown
- 1967-11-22 AT AT1056767A patent/AT283369B/de not_active IP Right Cessation
- 1967-11-22 FR FR1561137D patent/FR1561137A/fr not_active Expired
- 1967-11-22 ES ES347463A patent/ES347463A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK115922B (da) | 1969-11-24 |
| DE1670006A1 (de) | 1971-01-21 |
| SE324371B (de) | 1970-06-01 |
| AT283369B (de) | 1970-08-10 |
| US3523116A (en) | 1970-08-04 |
| ES347463A1 (es) | 1969-02-01 |
| FR1561137A (de) | 1969-03-28 |
| NL6715746A (de) | 1968-05-24 |
| CH483435A (de) | 1969-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO156328B (no) | Konstruksjon med keramisk overflatebelegg samt fremgangsmaate til fremstilling av samme. | |
| DK154563B (da) | Fremgangsmaade til fremstilling af en racemisk eller optisk aktiv (+)-thiolacton eller (+)-bioton | |
| NO853255L (no) | Fremgangsmaate for fremstilling av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-benzazepin. | |
| US20190047962A1 (en) | Process for the preparation of 4-alkoxy-3-acetoxypicolinic acids | |
| WO2006021974A1 (en) | A process for synthesizing diol (viii)-an intermediate of montelukast sodium | |
| DK149230B (da) | Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf | |
| JP2004500324A (ja) | ピペラジン環含有化合物の新規の合成及び結晶化 | |
| Stempel et al. | Quinazolines and 1, 4-Benzodiazepines. XXVII. 1 Mechanism of Ring Enlargement of Quinazoline 3-Oxides with Alkali2 to 1, 4-Benzodiazepin-2-one 4-Oxides | |
| NO120230B (de) | ||
| Santilli et al. | 8, 9, 10, 11-Tetrahydro-12H-benzo [5, 6] quinoxalino-[2, 3-e][1, 4] diazepin-12-ones. Examples of a New Heterocyclic Ring System | |
| US3983162A (en) | Optical resolution of alkyl esters of DL-phenylalanine | |
| SU1301311A3 (ru) | Способ получени производных гексагидроазепина или пиперидина, или пирролидина (его варианты) | |
| Bogert et al. | THE DIRECT SYNTHESIS OF KETODIHYDROQUINAZOLINS FROM ORTHOAMINO ACIDS. | |
| DE1545942A1 (de) | Verfahren zur Herstellung von Chinazolin-Derivaten | |
| US3297698A (en) | Process for the preparation of quinazoline 3-oxides | |
| Harwood et al. | Isoquinoline derivatives. III. 3-Isoquinolinecarboxylic acids | |
| NZ213473A (en) | Process for preparing quinazoline-2,4-diones | |
| US3301896A (en) | 1-(cyclopropylcarbonyl) ureas | |
| DK156391B (da) | Analogifremgangsmaade til fremstilling af 3-aminopyrrolderivater | |
| US2958692A (en) | S-carboxymethylmercapto-g- | |
| US1750082A (en) | manchester | |
| US3329677A (en) | N-benzhydryloxyphthalimides and pryidinealdehyde o-benzhydryloximes | |
| US3322764A (en) | Process for preparing n-substituted 2-aminobenzophenones utilizing 4-phenylquinazolines | |
| US3649643A (en) | N-phthalimidoacetyl-5-chloro-2-cyclopropyl-methylaminobenzhydrol | |
| NO176141B (no) | Fremgangsmåte for fremstilling av 1-((2S)-3-merkapto-methyl-1-oksopropyl)-L-prolin |